Le Pichon CE, et al. (2013) EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS. PLoS One 8(4):e62342
Paste the following link
Lists
This AllelePublication isn't in any lists. Upload a list.